Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Luis Jodar

Showing results (1-10 of 150) with videos related to

Pageof 15
Sort By:
Nature Medicine|April 7, 2005
Introducing new vaccines into developing countries: obstacles, opportunities and complexitiesJohn Clemens, Luis Jodar
Lancet (London, England)|July 12, 2005
Hib vaccines for all the world's children?John Clemens, Luis Jodar
Journal of Health, Population, and Nutrition|December 22, 2004
Translational research to assist policy decisions about introducing new vaccines in developing countriesJohn D Clemens, Luis Jodar
The New England Journal of Medicine|September 15, 2007
Putting typhoid vaccination on the global health agendaDenise DeRoeck, Luis Jodar, John Clemens
Vaccine|May 4, 2004
Technologies that make administration of vaccines saferC John Clements, Gordon Larsen, Luis Jodar
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|December 28, 2020
Re: 'Effects of 13-valent pneumococcal conjugate vaccination of adults on lower respiratory tract infections and antibiotic use in primary care' by van Werkhoven et alChristian Theilacker, Luis Jodar, Bradford D Gessner
Vaccine|July 23, 2019
Rethinking results from the Japanese 23-valent pneumococcal polysaccharide vaccine randomized clinical trialBradford D Gessner, Christian Theilacker, Luis Jodar
Biologicals : Journal of the International Association of Biological Standardization|December 12, 2002
Assay parameters and methods of data analysis for the comparison of complement sources in the Neisseria meningitidis serogroup C serum bactericidal assayLuis Jodar, David Stephens, Ian M Feavers
The Lancet. Infectious Diseases|June 29, 2019
Efficacy and effectiveness of ten-valent versus 13-valent pneumococcal conjugate vaccinesBradford D Gessner, Heather L Sings, Luis Jodar
Vaccine|July 2, 2021
Comment on "Vila-Córcoles et al., Clinical effectiveness of 13-valent and 23-valent pneumococcal vaccination in middle-aged and older adults: The EPIVAC cohort study, 2015-2016."Bradford D Gessner, Christian Theilacker, Cristina Méndez, et al.
Pageof 15

Showing results (1-10 of 150) with videos related to

Sort By:
Pageof 15
Nature Medicine|April 7, 2005
Introducing new vaccines into developing countries: obstacles, opportunities and complexitiesJohn Clemens, Luis Jodar
Lancet (London, England)|July 12, 2005
Hib vaccines for all the world's children?John Clemens, Luis Jodar
Journal of Health, Population, and Nutrition|December 22, 2004
Translational research to assist policy decisions about introducing new vaccines in developing countriesJohn D Clemens, Luis Jodar
The New England Journal of Medicine|September 15, 2007
Putting typhoid vaccination on the global health agendaDenise DeRoeck, Luis Jodar, John Clemens
Vaccine|May 4, 2004
Technologies that make administration of vaccines saferC John Clements, Gordon Larsen, Luis Jodar
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|December 28, 2020
Re: 'Effects of 13-valent pneumococcal conjugate vaccination of adults on lower respiratory tract infections and antibiotic use in primary care' by van Werkhoven et alChristian Theilacker, Luis Jodar, Bradford D Gessner
Vaccine|July 23, 2019
Rethinking results from the Japanese 23-valent pneumococcal polysaccharide vaccine randomized clinical trialBradford D Gessner, Christian Theilacker, Luis Jodar
Biologicals : Journal of the International Association of Biological Standardization|December 12, 2002
Assay parameters and methods of data analysis for the comparison of complement sources in the Neisseria meningitidis serogroup C serum bactericidal assayLuis Jodar, David Stephens, Ian M Feavers
The Lancet. Infectious Diseases|June 29, 2019
Efficacy and effectiveness of ten-valent versus 13-valent pneumococcal conjugate vaccinesBradford D Gessner, Heather L Sings, Luis Jodar
Vaccine|July 2, 2021
Comment on "Vila-Córcoles et al., Clinical effectiveness of 13-valent and 23-valent pneumococcal vaccination in middle-aged and older adults: The EPIVAC cohort study, 2015-2016."Bradford D Gessner, Christian Theilacker, Cristina Méndez, et al.
Pageof 15